연구동향 분석

Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis

Hyung Hoi Kim Kyung-Hwa Shin 권병수 Dong Soo Suh Jong-Kil Joo Ki Hyung Kim 2020년

논문상세정보
인용/피인용
' Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Cancer antigen 125
  • Cancer antigen 72-4
  • Human epididymis 4
  • Ovarian tumor
  • Risk of Ovarian Malignancy Algorithm
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7 0

0.0%

' Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis' 의 참고문헌

  • The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis
    Kadija S [2012]
  • The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
    Moore RG [2008]
  • The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer
    Anastasi E [2013]
  • The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass
    Chan KK [2013]
  • The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
    Scaletta G [2017]
  • The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors
    Ławicki S [2013]
  • Serum tumour markers in gynaecological cancers
    Aggarwal P [2010]
  • Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis : a systematic review
    Ferraro S [2013]
  • Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian management
    Bandiera E [2011]
  • Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
    Moore RG [2012]
  • Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
    Granato T [2012]
  • ROMA, an algorithm for ovarian cancer
  • Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors
    Lenhard MS [2009]
  • No benefit from combining HE4 and CA 125 as ovarian tumor markers in a clinical setting
    Jacob F [2011]
  • NCCN Guidelines Insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017
    Daly MB [2017]
  • HE4 and CA125 as a diagnostic test in ovarian cancer : prospective validation of the Risk of Ovarian Malignancy Algorithm
    Van Gorp T [2011]
  • Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray F [2018]
  • FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
    Jaime Prat [2015]
  • Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass
    Moore RG [2011]
  • Elevation of TP53 autoantibody before CA125 in preclinical invasive epithelial ovarian cancer
    Yang WL [2017]
  • Elevated human epididymis protein 4 concentrations in chronic kidney disease
    Nagy B Jr [2012]
  • Early detection of ovarian cancer using group biomarkers
    Tchagang AB [2008]
  • Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis
    Wang J [2014]
  • Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases
    Escudero JM [2011]
  • Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas
    Schummer M [1999]
  • Committee Opinion No. 716. Committee Opinion No. 716: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer in women at average risk
  • CA 72-4 serum marker—a new tool in the management of carcinoma patients
    Guadagni F [1995]
  • British Gynaecological Cancer Society (BGCS) epithelial ovarian/Fallopian tube/primary peritoneal cancer guidelines: recommendations for practice
  • A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
    Moore RG [2009]